// App-Quantinova.ai

e13052 : Comparison of treatment-related adverse events (TRAE) of different CDK4/6 inhibitors (CDK4/6i) in metastatic breast cancer (MBC): A network meta-analysis.

Researchers

Presenter

  • Alexandra Desnoyers

Principal Investigators

  • Michelle Nadler

  • Vikaash Kumar

  • Ramy Saleh

  • Eitan Amir

Medical Centers

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Cyclin-dependent kinase 4

Drug/Treatment

  • Abemaciclib

  • Fulvestrant

  • Palbociclib

  • Ribociclib

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved